Dr. Nathalie Krebs

Nathalie Krebs, MD, has been a member of the Supervisory Board of Brockhaus Technologies AG since June 2022.

After obtaining her doctorate in medicine from the University of Basel, which she successfully completed in 1999, she first worked for The Boston Consulting Group in strategic consulting, then for Altium Capital AG (now Houlihan Lokey) in corporate finance consulting with a focus on the healthcare, pharmaceutical and medical technology industries. At Bayer (Switzerland) AG and formerly Schering (Switzerland) AG she held various positions as Senior Divisional Director, Business Unit Manager, Head of External Affairs. Dr. Krebs has already held various mandates in supervisory bodies in Switzerland and has been Chairwoman of the Supervisory Board of aap Implantate AG (Berlin) since 2019.